These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6343 related articles for article (PubMed ID: 14533809)

  • 1. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
    Hakomori S
    Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines and carbohydrate epitopes.
    Heimburg-Molinaro J; Lum M; Vijay G; Jain M; Almogren A; Rittenhouse-Olson K
    Vaccine; 2011 Nov; 29(48):8802-26. PubMed ID: 21964054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traveling for the glycosphingolipid path.
    Hakomori S
    Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
    Horwacik I
    Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
    Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
    Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.
    Springer GF
    J Mol Med (Berl); 1997 Aug; 75(8):594-602. PubMed ID: 9297627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
    Feng D; Shaikh AS; Wang F
    ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.
    Zhang S; Zhang HS; Cordon-Cardo C; Reuter VE; Singhal AK; Lloyd KO; Livingston PO
    Int J Cancer; 1997 Sep; 73(1):50-6. PubMed ID: 9334809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific vaccines for cancer treatment.
    Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent development in carbohydrate-based cancer vaccines.
    Guo Z; Wang Q
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
    Beckwith DM; Cudic M
    Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines.
    Qiu J; Luo P; Wasmund K; Steplewski Z; Kieber-Emmons T
    Hybridoma; 1999 Feb; 18(1):103-12. PubMed ID: 10211797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigens as targets for active specific immunotherapy.
    Ragupathi G
    Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
    Berois N; Pittini A; Osinaga E
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA.
    Ravindranath MH; Bauer PM; Cornillez-Ty C; Garcia J; Morton DL
    J Immunol Methods; 1996 Oct; 197(1-2):51-67. PubMed ID: 8890894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated carbohydrate antigens of MUC1 - Implication in cancer development.
    Radziejewska I
    Biomed Pharmacother; 2024 May; 174():116619. PubMed ID: 38643541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 318.